Atsushi Sofuni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Atsushi Sofuni has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
- Takao Itoi
Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo 160-0023, Japan
69 shared publications - Takayoshi Tsuchiya
Department of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan
55 shared publications - Ryosuke Tonozuka
Department of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan
35 shared publications - Shuntaro Mukai
Department of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan
32 shared publications Reina Tanaka
Department of Gastroenterology and Hepatology, Tokyo, Japan
31 shared publications- Fumihide Itokawa
Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan
28 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-15
The clinical utility and diagnostic performance of transabdominal contrast-enhanced ultrasonography using Sonazoid for pancreatic diseases: a narrative review
This review aims to evaluate the clinical utility of contrast-enhanced ultrasonography (CEUS) in the differential diagnosis and management of solid and cystic pancreatic lesions. We reviewed the characteristic enhancement patterns of various solid and cystic pancreatic diseases, including pancreatic ductal adenocarcinoma (PDAC), mass-forming pancreatitis (MFP), focal autoimmune pancreatitis (AIP), pancreatic neuroendocrine neoplasms (PNENs), solid pseudopapillary neoplasms (SPNs), metastatic tumors, intraductal papillary mucinous neoplasms (IPMNs), serous cystic neoplasms (SCNs), and mucinous cystic neoplasms (MCNs). We also analyzed the role of quantitative perfusion analysis and summarized diagnostic performance based on multicenter studies and meta-analyses. In PDAC, the “irregular rolling sign” and early washout under a hypovascular pattern are critical diagnostic markers reflecting histological desmoplasia. Conversely, MFP typically shows diffuse isovascularity. CEUS facilitates the differentiation of malignant mural nodules from mucus plugs in IPMN with high accuracy. Quantitative perfusion analysis (QPA) using time-intensity curves (TIC) provides objective metrics like peak intensity (PI) and area under the curve (AUC), enhancing diagnostic objectivity. Large-scale studies, such as the Pancreatic Multicenter Ultrasound Study (PAMUS), and several meta-analyses have demonstrated that CEUS achieves a pooled sensitivity of 86–90% and specificity of 75–88% for pancreatic cancer, outperforming or equaling conventional CT and B-mode ultrasound. CEUS is a minimally invasive, rapid, and highly accurate modality that provides essential hemodynamic information. It should be considered a valuable complementary imaging modality for the initial evaluation and stratification of pancreatic neoplastic lesions, particularly when detailed hemodynamic assessment is required alongside conventional screening.
- 29 August 2026
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-15
Open AccessThe clinical utility and diagnostic performance of transabdominal contrast-enhanced ultrasonography using Sonazoid for pancreatic diseases: a narrative review
This review aims to evaluate the clinical utility of contrast-enhanced ultrasonography (CEUS) in the differential diagnosis and management of solid and cystic pancreatic lesions. We reviewed the characteristic enhancement patterns of various solid and cystic pancreatic diseases, including pancreatic ductal adenocarcinoma (PDAC), mass-forming pancreatitis (MFP), focal autoimmune pancreatitis (AIP), pancreatic neuroendocrine neoplasms (PNENs), solid pseudopapillary neoplasms (SPNs), metastatic tumors, intraductal papillary mucinous neoplasms (IPMNs), serous cystic neoplasms (SCNs), and mucinous cystic neoplasms (MCNs). We also analyzed the role of quantitative perfusion analysis and summarized diagnostic performance based on multicenter studies and meta-analyses. In PDAC, the “irregular rolling sign” and early washout under a hypovascular pattern are critical diagnostic markers reflecting histological desmoplasia. Conversely, MFP typically shows diffuse isovascularity. CEUS facilitates the differentiation of malignant mural nodules from mucus plugs in IPMN with high accuracy. Quantitative perfusion analysis (QPA) using time-intensity curves (TIC) provides objective metrics like peak intensity (PI) and area under the curve (AUC), enhancing diagnostic objectivity. Large-scale studies, such as the Pancreatic Multicenter Ultrasound Study (PAMUS), and several meta-analyses have demonstrated that CEUS achieves a pooled sensitivity of 86–90% and specificity of 75–88% for pancreatic cancer, outperforming or equaling conventional CT and B-mode ultrasound. CEUS is a minimally invasive, rapid, and highly accurate modality that provides essential hemodynamic information. It should be considered a valuable complementary imaging modality for the initial evaluation and stratification of pancreatic neoplastic lesions, particularly when detailed hemodynamic assessment is required alongside conventional screening.
- 29 November 2025
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 52 (3) , 514-523
First-in-Human Safety and Efficacy Study on Combination of High-Intensity Focused Ultrasound Sonication and Micellar Nanoparticle-Encapsulated Epirubicin, K-912: A Novel Sonodynamic Therapy for the Treatment of Refractory Abdominal Cancers
- 29 November 2025
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 52 (3) , 514-523
First-in-Human Safety and Efficacy Study on Combination of High-Intensity Focused Ultrasound Sonication and Micellar Nanoparticle-Encapsulated Epirubicin, K-912: A Novel Sonodynamic Therapy for the Treatment of Refractory Abdominal Cancers
- Open Access
- 6 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 130
Protocol for a Multi-Center Confirmatory Trial to Evaluate the Differential Diagnostic Performance of Contrast-Enhanced Ultrasonography Using Perflubutane in Patients with a Pancreatic Mass: A Multicenter Prospective Study
For pancreatic masses, an evaluation of their vascularity using contrast-enhanced ultrasonography can help improve their characterization. This study was designed to evaluate the utility and safety of contrast-enhanced transabdominal ultrasonography (CE-TUS) and endoscopic ultrasonography (CE-EUS) in the diagnosis of pancreatic masses including solid or cystic masses. This multi-center comparative open-label superiority study is designed to compare Plain (P)-TUS/EUS alone with P-TUS/P-EUS plus CE-TUS/CE-EUS. Three hundred and one patients with a total of 232 solid pancreatic masses and 69 cystic masses were prospectively enrolled. The primary endpoints are to compare the diagnostic accuracy between P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for both the TUS and EUS of solid pancreatic masses, and to compare the diagnostic accuracy between P-EUS alone and P-EUS plus CE-EUS in cystic pancreatic masses. The secondary endpoints are to compare the diagnostic sensitivity and specificity of P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for pancreatic solid/cystic masses, and the accuracy of P-TUS alone and P-TUS plus CE-TUS for pancreatic cystic masses. Other secondary endpoints included comparing the diagnostic sensitivity, specificity, and accuracy of CE-TUS, CE-EUS and CE-computed tomography (CT) for solid/cystic pancreatic masses. The safety, degree of effective enhancement, and diagnostic confidence obtained with CE-TUS/CE-EUS will also be assessed.
- 6 January 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (2) , 130
Open AccessProtocol for a Multi-Center Confirmatory Trial to Evaluate the Differential Diagnostic Performance of Contrast-Enhanced Ultrasonography Using Perflubutane in Patients with a Pancreatic Mass: A Multicenter Prospective Study
For pancreatic masses, an evaluation of their vascularity using contrast-enhanced ultrasonography can help improve their characterization. This study was designed to evaluate the utility and safety of contrast-enhanced transabdominal ultrasonography (CE-TUS) and endoscopic ultrasonography (CE-EUS) in the diagnosis of pancreatic masses including solid or cystic masses. This multi-center comparative open-label superiority study is designed to compare Plain (P)-TUS/EUS alone with P-TUS/P-EUS plus CE-TUS/CE-EUS. Three hundred and one patients with a total of 232 solid pancreatic masses and 69 cystic masses were prospectively enrolled. The primary endpoints are to compare the diagnostic accuracy between P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for both the TUS and EUS of solid pancreatic masses, and to compare the diagnostic accuracy between P-EUS alone and P-EUS plus CE-EUS in cystic pancreatic masses. The secondary endpoints are to compare the diagnostic sensitivity and specificity of P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for pancreatic solid/cystic masses, and the accuracy of P-TUS alone and P-TUS plus CE-TUS for pancreatic cystic masses. Other secondary endpoints included comparing the diagnostic sensitivity, specificity, and accuracy of CE-TUS, CE-EUS and CE-computed tomography (CT) for solid/cystic pancreatic masses. The safety, degree of effective enhancement, and diagnostic confidence obtained with CE-TUS/CE-EUS will also be assessed.
- Open Access
- 3 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (44) , e35701
A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case report
Introduction: In median arcuate ligament syndrome (MALS), the celiac artery is compressed, causing an arcade to develop in the pancreatic head, leading to ischemic symptoms and aneurysms. Patient concerns: The patient was diagnosed with borderline resectable pancreatic cancer (PC) and MALS. Endoscopic biliary drainage with a covered metal stent (CMS) was performed for the obstructive jaundice. After the jaundice improved, a modified FOLFIRINOX regimen was initiated. Several days later, cardiopulmonary arrest occurred after hematemesis occurred. Cardiopulmonary resuscitation was performed, his blood pressure stabilized, and emergent upper endoscopy was performed. The CMS was dislodged and active bleeding was observed in the papillae. The CMS was replaced, and temporary hemostasis was achieved. Contrast-enhanced computed tomography revealed a diagnosis of extravasation from the posterior superior pancreaticoduodenal artery (PSPDA) into the biliary tract. Transcatheter arterial embolization was performed. However, the patient was subsequently diagnosed with hypoxic encephalopathy and died on day 14 of hospitalization. Diagnosis: Biliary hemorrhage due to invasion of pancreatic cancer from the PSPDA associated with MALS. Intervention: None. Outcomes: Biliary hemorrhage from the PSPDA was fatal in the patient with invasive PC with MALS. Lessons: Since MALS associated with PC is not a rare disease, the purpose of this study was to keep in mind the possibility of fatal biliary hemorrhage.
- 3 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (44) , e35701
Open AccessA fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case report
Introduction: In median arcuate ligament syndrome (MALS), the celiac artery is compressed, causing an arcade to develop in the pancreatic head, leading to ischemic symptoms and aneurysms. Patient concerns: The patient was diagnosed with borderline resectable pancreatic cancer (PC) and MALS. Endoscopic biliary drainage with a covered metal stent (CMS) was performed for the obstructive jaundice. After the jaundice improved, a modified FOLFIRINOX regimen was initiated. Several days later, cardiopulmonary arrest occurred after hematemesis occurred. Cardiopulmonary resuscitation was performed, his blood pressure stabilized, and emergent upper endoscopy was performed. The CMS was dislodged and active bleeding was observed in the papillae. The CMS was replaced, and temporary hemostasis was achieved. Contrast-enhanced computed tomography revealed a diagnosis of extravasation from the posterior superior pancreaticoduodenal artery (PSPDA) into the biliary tract. Transcatheter arterial embolization was performed. However, the patient was subsequently diagnosed with hypoxic encephalopathy and died on day 14 of hospitalization. Diagnosis: Biliary hemorrhage due to invasion of pancreatic cancer from the PSPDA associated with MALS. Intervention: None. Outcomes: Biliary hemorrhage from the PSPDA was fatal in the patient with invasive PC with MALS. Lessons: Since MALS associated with PC is not a rare disease, the purpose of this study was to keep in mind the possibility of fatal biliary hemorrhage.
- 12 October 2022
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-12
Current status and future perspective of sonodynamic therapy for cancer
- 12 October 2022
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-12
Current status and future perspective of sonodynamic therapy for cancer
- 15 September 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 30 (3) , 401-407
A novel peroral digital cholangioscope with a large accessory channel: An experimental study
Background/Purpose: A peroral cholangioscope (POCS) can allow direct visualization of the biliary mucosa and its use is becoming more widespread due to improvements in functionality, image quality, and operability, as well as the development of related devices. Recently, a novel mother‐baby peroral cholangioscope (nMB‐POCS) with a large (2‐mm) accessory channel has been developed. In this study, we evaluated the feasibility of this novel POCS in a dry simulation and animal model.Methods: We evaluated the ease of insertion and maneuverability of the nMB‐POCS, the image quality, and the passage of the devices into the accessory channel and into the common bile duct in a dry and live porcine model.Results: In both models, the nMB‐POCS could be easily inserted into the duodenoscope and into the distal bile duct and hilum. The image quality was good, and it was possible to observe the surface structure and the vascular network of the bile duct mucosa in detail.Conclusions: The nMB‐POCS with its larger accessory channel is expected to improve the efficiency of diagnosis and treatment, and reduce the procedure time. Clinical studies in patients are warranted.
- 15 September 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 30 (3) , 401-407
A novel peroral digital cholangioscope with a large accessory channel: An experimental study
Background/Purpose: A peroral cholangioscope (POCS) can allow direct visualization of the biliary mucosa and its use is becoming more widespread due to improvements in functionality, image quality, and operability, as well as the development of related devices. Recently, a novel mother‐baby peroral cholangioscope (nMB‐POCS) with a large (2‐mm) accessory channel has been developed. In this study, we evaluated the feasibility of this novel POCS in a dry simulation and animal model.Methods: We evaluated the ease of insertion and maneuverability of the nMB‐POCS, the image quality, and the passage of the devices into the accessory channel and into the common bile duct in a dry and live porcine model.Results: In both models, the nMB‐POCS could be easily inserted into the duodenoscope and into the distal bile duct and hilum. The image quality was good, and it was possible to observe the surface structure and the vascular network of the bile duct mucosa in detail.Conclusions: The nMB‐POCS with its larger accessory channel is expected to improve the efficiency of diagnosis and treatment, and reduce the procedure time. Clinical studies in patients are warranted.
- 19 August 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 30 (3) , 351-359
Efficacy of shear wave elastography for the diagnosis of chronic pancreatitis
Background/Purpose: Shear wave elastography (SWE) is a clinical method used to evaluate liver hardness. In this study, we assessed its applicability in assessing the pancreas and its potential for diagnosing chronic pancreatitis.Methods: We performed SWE on 59 patients who underwent abdominal ultrasound, and measured the computed tomography (CT) values of the pancreas. Patients were classified as having a normal pancreas (NP), early chronic pancreatitis (ECP), or chronic pancreatitis (CP). SW elasticity (SWe), SW dispersion (SWd), and CT values between groups were analyzed.Results: SWe significantly differed between the CP and NP/ECP groups (NP vs CP; P = 0.001, ECP vs CP; P = 0.026,), while SWd showed a significant difference only between the NP and CP group (NP vs CP; P = 0.001). The CT values were significantly different between the CP and NP/ECP groups (NP vs CP; P = 0.0006, ECP vs CP; P = 0.0027).Conclusion: Pancreatic SWE and CT values were helpful in the diagnosis of chronic pancreatitis. SWd may reveal status changes in ECP.
- 19 August 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 30 (3) , 351-359
Efficacy of shear wave elastography for the diagnosis of chronic pancreatitis
Background/Purpose: Shear wave elastography (SWE) is a clinical method used to evaluate liver hardness. In this study, we assessed its applicability in assessing the pancreas and its potential for diagnosing chronic pancreatitis.Methods: We performed SWE on 59 patients who underwent abdominal ultrasound, and measured the computed tomography (CT) values of the pancreas. Patients were classified as having a normal pancreas (NP), early chronic pancreatitis (ECP), or chronic pancreatitis (CP). SW elasticity (SWe), SW dispersion (SWd), and CT values between groups were analyzed.Results: SWe significantly differed between the CP and NP/ECP groups (NP vs CP; P = 0.001, ECP vs CP; P = 0.026,), while SWd showed a significant difference only between the NP and CP group (NP vs CP; P = 0.001). The CT values were significantly different between the CP and NP/ECP groups (NP vs CP; P = 0.0006, ECP vs CP; P = 0.0027).Conclusion: Pancreatic SWE and CT values were helpful in the diagnosis of chronic pancreatitis. SWd may reveal status changes in ECP.
- Open Access
- 12 May 2022
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-9
High-intensity focused ultrasound therapy for pancreatic cancer
Pancreatic cancer (PC) has one of the poorest prognoses among solid cancers, and its incidence has increased recently. Satisfactory outcomes are not achieved with current therapies; thus, novel treatments are urgently needed. High-intensity focused ultrasound (HIFU) is a novel therapy for ablating tissue from the outside of the body by focusing ultrasonic waves from multiple sources on the tumor. In this therapy, only the focal area is heated to 80–100 ºC, which causes coagulative necrosis of the tissue, with hardly any impact on the tissue outside the focal area. Although HIFU is a minimally invasive treatment and is expected to be useful, it is not yet generally known. Here, we discuss the usefulness of HIFU treatment for un-resectable advanced PC using the results of previous research, meta-analyses, and systematic reviews on its efficacy and safety. HIFU therapy for un-resectable PC is useful for its anti-tumor effect and pain relief, and is expected to prolong survival time and improve quality of life. Although HIFU for PC has several limitations and further study is needed, this technique can be safely performed on un-resectable advanced PC. In future, HIFU could be utilized as a minimally invasive treatment strategy for PC patients with a poor prognosis.
- 12 May 2022
- Published by Springer Nature in Journal of Medical Ultrasonics
- p. 1-9
Open AccessHigh-intensity focused ultrasound therapy for pancreatic cancer
Pancreatic cancer (PC) has one of the poorest prognoses among solid cancers, and its incidence has increased recently. Satisfactory outcomes are not achieved with current therapies; thus, novel treatments are urgently needed. High-intensity focused ultrasound (HIFU) is a novel therapy for ablating tissue from the outside of the body by focusing ultrasonic waves from multiple sources on the tumor. In this therapy, only the focal area is heated to 80–100 ºC, which causes coagulative necrosis of the tissue, with hardly any impact on the tissue outside the focal area. Although HIFU is a minimally invasive treatment and is expected to be useful, it is not yet generally known. Here, we discuss the usefulness of HIFU treatment for un-resectable advanced PC using the results of previous research, meta-analyses, and systematic reviews on its efficacy and safety. HIFU therapy for un-resectable PC is useful for its anti-tumor effect and pain relief, and is expected to prolong survival time and improve quality of life. Although HIFU for PC has several limitations and further study is needed, this technique can be safely performed on un-resectable advanced PC. In future, HIFU could be utilized as a minimally invasive treatment strategy for PC patients with a poor prognosis.
- Open Access
- 1 December 2021
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 60 (23) , 3737-3741
Severe Acute Cholangitis and Bacteremia Due to Campylobacter jejuni: A Case Report and Review of the Literature
Campylobacter jejuni is common cause of enteritis, but biliary infection rarely reported. An 82-year-old woman with pancreatic head cancer underwent endoscopic biliary drainage for malignant biliary obstruction. She was subsequently admitted for management of diarrhea. C. jejuni was identified in stool culture. Her symptoms resolved temporarily without antibiotics but flared up with a fever a few days later. She was diagnosed with acute cholangitis and bacteremia with C. jejuni. Endoscopic biliary drainage and antimicrobial administration improved her symptoms. As complications of C. jejuni diarrhea are rare, antibiotics are not necessarily indicated but sometimes are needed to prevent complications.
- 1 December 2021
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 60 (23) , 3737-3741
Open AccessSevere Acute Cholangitis and Bacteremia Due to Campylobacter jejuni: A Case Report and Review of the Literature
Campylobacter jejuni is common cause of enteritis, but biliary infection rarely reported. An 82-year-old woman with pancreatic head cancer underwent endoscopic biliary drainage for malignant biliary obstruction. She was subsequently admitted for management of diarrhea. C. jejuni was identified in stool culture. Her symptoms resolved temporarily without antibiotics but flared up with a fever a few days later. She was diagnosed with acute cholangitis and bacteremia with C. jejuni. Endoscopic biliary drainage and antimicrobial administration improved her symptoms. As complications of C. jejuni diarrhea are rare, antibiotics are not necessarily indicated but sometimes are needed to prevent complications.
- Open Access
- 20 November 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (6) , 4845-4861
Novel Therapeutic Method for Unresectable Pancreatic Cancer—The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy
High-intensity focused ultrasound (HIFU) is a novel advanced therapy for unresectable pancreatic cancer (PC). HIFU therapy with chemotherapy is being promoted as a novel method to control local advancement by tumor ablation. We evaluated the therapeutic effects of HIFU therapy in locally advanced and metastatic PC. PC patients were treated with HIFU as an optional local therapy and systemic chemotherapy. The FEP-BY02 (Yuande Bio-Medical Engineering) HIFU device was used under ultrasound guidance. Of 176 PC patients, 89 cases were Stage III and 87 were Stage IV. The rate of complete tumor ablation was 90.3%, while that of symptom relief was 66.7%. The effectiveness on the primary lesions were as follows: complete response (CR): n = 0, partial response (PR): n = 21, stable disease (SD): n = 106, and progressive disease (PD): n = 49; the primary disease control rate was 72.2%. Eight patients underwent surgery. The median survival time (MST) after diagnosis for HIFU with chemotherapy compared to chemotherapy alone (100 patients in our hospital) was 648 vs. 288 days (p < 0.001). Compared with chemotherapy alone, the combination of HIFU therapy and chemotherapy demonstrated significant prolongation of prognosis. This study suggests that HIFU therapy has the potential to be a novel combination therapy for unresectable PC.
- 20 November 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (6) , 4845-4861
Open AccessNovel Therapeutic Method for Unresectable Pancreatic Cancer—The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy
High-intensity focused ultrasound (HIFU) is a novel advanced therapy for unresectable pancreatic cancer (PC). HIFU therapy with chemotherapy is being promoted as a novel method to control local advancement by tumor ablation. We evaluated the therapeutic effects of HIFU therapy in locally advanced and metastatic PC. PC patients were treated with HIFU as an optional local therapy and systemic chemotherapy. The FEP-BY02 (Yuande Bio-Medical Engineering) HIFU device was used under ultrasound guidance. Of 176 PC patients, 89 cases were Stage III and 87 were Stage IV. The rate of complete tumor ablation was 90.3%, while that of symptom relief was 66.7%. The effectiveness on the primary lesions were as follows: complete response (CR): n = 0, partial response (PR): n = 21, stable disease (SD): n = 106, and progressive disease (PD): n = 49; the primary disease control rate was 72.2%. Eight patients underwent surgery. The median survival time (MST) after diagnosis for HIFU with chemotherapy compared to chemotherapy alone (100 patients in our hospital) was 648 vs. 288 days (p < 0.001). Compared with chemotherapy alone, the combination of HIFU therapy and chemotherapy demonstrated significant prolongation of prognosis. This study suggests that HIFU therapy has the potential to be a novel combination therapy for unresectable PC.